Literature DB >> 20463637

Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure?

Patrizia Burra1, Giacomo Germani, Annalisa Masier, Eleonora De Martin, Martina Gambato, Andrea Salonia, Patrizio Bo, Alessandro Vitale, Umberto Cillo, Francesco Paolo Russo, Marco Senzolo.   

Abstract

The goal of liver transplantation is not only to ensure patient long-term survival but also to offer the opportunity to achieve psychologic and physical integrity. Quality of life after liver transplantation may be affected by unsatisfactory sexual function. Before liver transplantation, sexual dysfunction and sex hormone disturbances are reported in men and women mainly due to abnormality of physiology of the hypothalamic-pituitary-gonadal axis and, in some cases, origin of liver disease. Successful liver transplantation should theoretically restore hormonal balance and improve sexual function both in men and women, thus improving the reproductive performance. However, after transplantation, up to 25% of patients report persistent sexual dysfunction, and approximately one third of patients describe the appearance of de novo sexual dysfunction. Despite the described high prevalence of this condition, epidemiologic data are relatively scant. Further studies on pathophysiology and risk factors in the field of sexual function after liver transplantation along with new strategies to support and inform patients on the waiting list and after surgery are needed.

Entities:  

Mesh:

Year:  2010        PMID: 20463637     DOI: 10.1097/TP.0b013e3181e1f1f6

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Symptom distress in patients with end-stage liver disease toward the end of life.

Authors:  Lissi Hansen; Michael C Leo; Michael F Chang; Atif Zaman; Willscott Naugler; Jonathan Schwartz
Journal:  Gastroenterol Nurs       Date:  2015 May-Jun       Impact factor: 0.978

Review 2.  Female gender in the setting of liver transplantation.

Authors:  Kryssia Isabel Rodríguez-Castro; Eleonora De Martin; Martina Gambato; Silvia Lazzaro; Erica Villa; Patrizia Burra
Journal:  World J Transplant       Date:  2014-12-24

Review 3.  Osteoporosis in liver disease: pathogenesis and management.

Authors:  Gabriela Handzlik-Orlik; Michał Holecki; Krzysztof Wilczyński; Jan Duława
Journal:  Ther Adv Endocrinol Metab       Date:  2016-04-06       Impact factor: 3.565

Review 4.  Diagnosis of alcoholic liver disease.

Authors:  Cara Torruellas; Samuel W French; Valentina Medici
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 5.  [Urological aspects in patients with liver cirrhosis].

Authors:  A Friedl; R Schwarzer; J Schneeweiss; C Brössner
Journal:  Urologe A       Date:  2016-01       Impact factor: 0.639

6.  Analysis of Quality of Life, Depression, and Sexual Function in Patients on the Liver Transplant List.

Authors:  Cihan Fidan; Aydıncan Akdur; Mahir Kırnap; Haldun Selçuk; Sedat Yıldırım; Gökhan Moray; Mehmet Haberal
Journal:  Turk J Gastroenterol       Date:  2021-09       Impact factor: 1.555

Review 7.  Outcomes in liver transplantation: does sex matter?

Authors:  Monika Sarkar; Kymberly D Watt; Norah Terrault; Marina Berenguer
Journal:  J Hepatol       Date:  2014-11-27       Impact factor: 25.083

8.  Erectile function in men with end-stage liver disease improves after living donor liver transplantation.

Authors:  You-Chiuan Chien; Heng-Chieh Chiang; Ping-Yi Lin; Yao-Li Chen
Journal:  BMC Urol       Date:  2015-08-13       Impact factor: 2.264

9.  Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis.

Authors:  Jen-Kuei Peng; Nilay Hepgul; Irene J Higginson; Wei Gao
Journal:  Palliat Med       Date:  2018-10-22       Impact factor: 4.762

10.  Assessing men with erectile dysfunction before and after living donor liver transplantation in real-world practice: Integrating laboratories into clinical settings.

Authors:  Heng-Chieh Chiang; You-Chiuan Chien; Ping-Yi Lin; Hsiu-Ling Lee; Yao-Li Chen
Journal:  PLoS One       Date:  2018-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.